At the American Diabetes Association meeting in New Orleans, market leader Eli Lilly and Co. asserted its dominance in the weight-loss market.

(Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that the first detailed preclinical characterization of ...

By Stephen Nellis and Kenrick Cai CUPERTINO, California, June 8 (Reuters) - Apple on Monday will test its standing in the AI ...

Hexiris Ophthalmics, a Canadian ophthalmic device company developing a new generation of technologies to expand access to interventional glaucoma care, today ...